Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behring Institute Mitteilungen

Showing results (61-70 of 617) with videos related to

Pageof 62
Sort By:
Behring Institute Mitteilungen|June 1, 1995
Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseasesS Nasert, M Millner, U Herz, et al.
Behring Institute Mitteilungen|June 1, 1995
Monomeric and dimeric forms of soluble receptors can differ in their neutralization potentialL Lauffer, E J Kanzy, R Köhler, et al.
Behring Institute Mitteilungen|June 1, 1995
Signal transduction by the IL-1 type I receptor: evidence for the involvement of a receptor-coupled protein kinaseM Martin, R Brigelius-Flohé, K Resch
Behring Institute Mitteilungen|June 1, 1995
Regulation of IL-1 activity by soluble IL-1 receptorsR Kurrle, L Lauffer, J Röder, et al.
Behring Institute Mitteilungen|June 1, 1995
Converging and diverging properties of human interleukin-4 and interleukin-10J Banchereau
Behring Institute Mitteilungen|October 1, 1996
CD95 (APO-1/Fas) and its ligand in the mouse immune systemS M Mariani, B Matiba, P H Krammer
Behring Institute Mitteilungen|October 1, 1996
The role of p53 as a transcription factor in the induction of apoptosisE Yonish-Rouach, C Choisy, V Deguin, et al.
Behring Institute Mitteilungen|October 1, 1996
Mechanisms of Bcl-2 family protein function and dysfunction in health and diseaseJ C Reed
Behring Institute Mitteilungen|October 1, 1996
Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnoverL E French, J Tschopp
Behring Institute Mitteilungen|October 1, 1996
FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and diseaseD H Lynch, K A Campbell, R E Miller, et al.
Pageof 62

Showing results (61-70 of 617) with videos related to

Sort By:
Pageof 62
Behring Institute Mitteilungen|June 1, 1995
Therapeutic interference with interferon-gamma (IFN-gamma) and soluble IL-4 receptor (sIL-4R) in allergic diseasesS Nasert, M Millner, U Herz, et al.
Behring Institute Mitteilungen|June 1, 1995
Monomeric and dimeric forms of soluble receptors can differ in their neutralization potentialL Lauffer, E J Kanzy, R Köhler, et al.
Behring Institute Mitteilungen|June 1, 1995
Signal transduction by the IL-1 type I receptor: evidence for the involvement of a receptor-coupled protein kinaseM Martin, R Brigelius-Flohé, K Resch
Behring Institute Mitteilungen|June 1, 1995
Regulation of IL-1 activity by soluble IL-1 receptorsR Kurrle, L Lauffer, J Röder, et al.
Behring Institute Mitteilungen|June 1, 1995
Converging and diverging properties of human interleukin-4 and interleukin-10J Banchereau
Behring Institute Mitteilungen|October 1, 1996
CD95 (APO-1/Fas) and its ligand in the mouse immune systemS M Mariani, B Matiba, P H Krammer
Behring Institute Mitteilungen|October 1, 1996
The role of p53 as a transcription factor in the induction of apoptosisE Yonish-Rouach, C Choisy, V Deguin, et al.
Behring Institute Mitteilungen|October 1, 1996
Mechanisms of Bcl-2 family protein function and dysfunction in health and diseaseJ C Reed
Behring Institute Mitteilungen|October 1, 1996
Constitutive Fas ligand expression in several non-lymphoid mouse tissues: implications for immune-protection and cell turnoverL E French, J Tschopp
Behring Institute Mitteilungen|October 1, 1996
FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and diseaseD H Lynch, K A Campbell, R E Miller, et al.
Pageof 62